Function of HNF1 in the pathogenesis of diabetes

References

• Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med.345, 971–980 (2001).
   PubMed Web of Science ®Google Scholar
• Vaxillaire M, Froguel P. Genetic basis of maturity-onset diabetes of the young. Endocrinol. Metab. Clin. North Am.35, 371–384 (2006).
   Google Scholar
• Gupta RK, Kaestner KH. HNF-4α: from MODY to late-onset Type 2 diabetes. Trends. Mol. Med.10, 521–524 (2004).
   PubMed Web of Science ®Google Scholar
• Bonnycastle LL, Willer CJ, Conneely KN et al. Common variants in maturity-onset diabetes of the young genes contribute to risk of Type 2 diabetes in Finns. Diabetes55, 2534–2540 (2006).
   PubMed Web of Science ®Google Scholar
• Shaat N, Karlsson E, Lernmark A et al. Common variants in MODY genes increase the risk of gestational diabetes mellitus. Diabetologia49, 1545–1551 (2006).
   PubMed Web of Science ®Google Scholar
• Yamagata K, Furuta H, Oda N et al. Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature384, 458–460 (1996).
   PubMed Web of Science ®Google Scholar
• Chen WS, Manova K, Weinstein DC et al. Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. Genes Dev.8, 2466–2477 (1994).
   PubMed Web of Science ®Google Scholar
• Froguel P, Zouali H, Vionnet N et al. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N. Engl. J. Med.328, 697–702 (1993).
   PubMed Web of Science ®Google Scholar
• Grupe A, Hultgren B, Ryan A, Ma YH, Bauer M, Stewart TA. Transgenic knockouts reveal a critical requirement for pancreatic β cell glucokinase in maintaining glucose homeostasis. Cell83, 69–78 (1995).
   PubMed Web of Science ®Google Scholar
• Terauchi Y, Sakura H, Yasuda K et al. Pancreatic β-cell-specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose. J. Biol. Chem.270, 30253–30256 (1995).
   PubMed Web of Science ®Google Scholar
• Yamagata K, Oda N, Kaisaki PJ et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature384, 455–458 (1996).
   PubMed Web of Science ®Google Scholar
• Lee YH, Sauer B, Gonzalez FJ. Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1α knockout mouse. Mol. Cell. Biol.18, 3059–3068 (1998).
   PubMed Web of Science ®Google Scholar
• Stoffers DA, Ferrer J, Clarke WL, Habener JF. Early-onset Type-II diabetes mellitus (MODY4) linked to IPF1. Nat. Genet.17, 138–139 (1997).
   PubMed Web of Science ®Google Scholar
• Jonsson J, Carlsson L, Edlund T, Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature371, 606–609 (1994).
   PubMed Web of Science ®Google Scholar
• Horikawa Y, Iwasaki N, Hara M et al. Mutation in hepatocyte nuclear factor-1β gene (TCF2) associated with MODY. Nat. Genet.17, 384–385 (1997).
   PubMed Web of Science ®Google Scholar
• Barbacci E, Reber M, Ott MO, Breillat C, Huetz F, Cereghini S. Variant hepatocyte nuclear factor 1 is required for visceral endoderm specification. Development126, 4795–4805 (1999).
   PubMed Web of Science ®Google Scholar
• Coffinier C, Thepot D, Babinet C, Yaniv M, Barra J. Essential role for the homeoprotein vHNF1/HNF1β in visceral endoderm differentiation. Development126, 4785–4794 (1999).
   PubMed Web of Science ®Google Scholar
• Malecki MT, Jhala US, Antonellis A et al. Mutations in NEUROD1 are associated with the development of Type 2 diabetes mellitus. Nat. Genet.23, 323–328 (1999).
   PubMed Web of Science ®Google Scholar
• Liu M, Pleasure SJ, Collins AE et al. Loss of BETA2/NeuroD leads to malformation of the dentate gyrus and epilepsy. Proc. Natl Acad. Sci. USA97, 865–780 (2000).
   PubMedGoogle Scholar
• Huang HP, Chu K, Nemoz-Gaillard E, Elberg D, Tsai MJ. Neogenesis of β-cells in adult BETA2/NeuroD-deficient mice. Mol. Endocrinol.16, 541–551 (2002).
   PubMedGoogle Scholar
• Hattersley AT, Pearson ER. Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, β-cell physiology, and genetics in diabetes. Endocrinology147, 2657–2663 (2006).
   PubMed Web of Science ®Google Scholar
• Schuit FC, Huypens P, Heimberg H, Pipeleers DG. Glucose sensing in pancreatic β-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes50, 1–11 (2001).
   PubMed Web of Science ®Google Scholar
• Navas MA, EJ Munoz-Elias Kim J, Shih D, Stoffel M. Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4(V255M), and HNF4(E276Q). Diabetes48, 1459–1465 (1999).
   PubMed Web of Science ®Google Scholar
• Vaxillaire M, Abderrahmani A, Boutin P et al. Anatomy of a homeoprotein revealed by the analysis of human MODY3 mutations. J. Biol. Chem.274, 35639–35646 (1999).
   Google Scholar
• Tomura H, Nishigori H, Sho K, Yamagata K, Inoue I, Takeda J. Loss-of-function and dominant-negative mechanisms associated with hepatocyte nuclear factor-1β mutations in familial Type 2 diabetes mellitus. J. Biol. Chem.274, 12975–12978 (1999).
   Google Scholar
• Furuta H, Furuta M, Sanke T et al. Nonsense and missense mutations in the human hepatocyte nuclear factor-1β gene (TCF2) and their relation to Type 2 diabetes in Japanese. J. Clin. Endocrinol. Metab.87, 3859–3863 (2002).
   PubMed Web of Science ®Google Scholar
• Neve B, ME Fernandez-Zapico V Ashkenazi-Katalan et al. Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic β cell function. Proc. Natl Acad. Sci. USA102, 4807–4812 (2005).
   PubMedGoogle Scholar
• Raeder H, Johansson S, Holm PI et al. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat. Genet.38, 54–62 (2006).
   PubMed Web of Science ®Google Scholar
• Mendel DB, Crabtree GR. HNF-1, a member of a novel class of dimerizing homeodomain proteins. J. Biol. Chem.266, 677–680 (1991).
   PubMed Web of Science ®Google Scholar
• Cereghini S, Raymondjean M, Carranca AG, Herbomel P, Yaniv M. Factors involved in control of tissue-specific expression of albumin gene. Cell50, 627–638 (1987).
   PubMed Web of Science ®Google Scholar
• Courtois G, Baumhueter S, Crabtree GR. Purified hepatocyte nuclear factor 1 interacts with a family of hepatocyte-specific promoters. Proc. Natl Acad. Sci. USA85, 7937–7941 (1988).
   PubMedGoogle Scholar
• Frain M, Swart G, Monaci P et al. The liver-specific transcription factor LF-B1 contains a highly diverged homeobox DNA binding domain. Cell59, 145–157 (1989).
   PubMed Web of Science ®Google Scholar
• De Simone V, De Magistris L, Lazzaro D et al. LFB3, a heterodimer-forming homeoprotein of the LFB1 family, is expressed in specialized epithelia. EMBO J.10, 1435–1443 (1991).
   PubMed Web of Science ®Google Scholar
• Bach I, Mattei MG, Cereghini S, Yaniv M. Two members of an HNF1 homeoprotein family are expressed in human liver. Nucleic Acids Res.19, 3553–3559 (1991).
   PubMedGoogle Scholar
• Mendel DB, Hansen LP, Graves MK, Conley PB, Crabtree GR. Hnf-1α and HNF-1β (vHNF-1) share dimerization and homeo domains, but not activation domains, and form heterodimers in vitro. Genes Dev.5, 1042–1056 (1991).
   PubMed Web of Science ®Google Scholar
• Nicosia A, Monaci P, Tomei L et al. A myosin-like dimerization helix and an extra-large homeodomain are essential elements of the tripartite DNA binding structure of LFB1. Cell61, 1225–1236 (1990).
   PubMed Web of Science ®Google Scholar
• Rey-Campos J, Chouard T, Yaniv M, Cereghini S. vHNF1 is a homeoprotein that activates transcription and forms heterodimers with HNF1. EMBO J.10, 1445–1457 (1991).
   PubMed Web of Science ®Google Scholar
• Ringeisen F, J Rey-Campos Yaniv M. The transactivation potential of variant hepatocyte nuclear factor 1 is modified by alternative splicing. J. Biol. Chem.268, 25706–25711 (1993).
   PubMed Web of Science ®Google Scholar
• Serfas MS, Tyner AL. Hnf-1α and HNF-1β expression in mouse intestinal crypts. Am. J. Physiol.265, G506–G513 (1993).
   PubMedGoogle Scholar
• Miquerol L, Lopez S, Cartier N, Tulliez M, Raymondjean M, Kahn A. Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas. J. Biol. Chem.269, 8944–8951 (1994).
   PubMed Web of Science ®Google Scholar
• Cereghini S. Liver-enriched transcription factors and hepatocyte differentiation. FASEB J.10, 267–282 (1996).
   PubMed Web of Science ®Google Scholar
• Hagenfeldt-Johansson KA, Herrera PL, Wang H, Gjinovci A, Ishihara H, Wollheim CB. β-cell-targeted expression of a dominant-negative hepatocyte nuclear factor-1α induces a maturity-onset diabetes of the young (MODY)3- like phenotype in transgenic mice. Endocrinology142, 5311–5320 (2001).
   PubMed Web of Science ®Google Scholar
• Maestro MA, Boj SF, Luco RF et al. Hnf6 and Tcf2 (MODY5) are linked in a gene network operating in a precursor cell domain of the embryonic pancreas. Hum. Mol. Genet.12, 3307–3314 (2003).
   PubMed Web of Science ®Google Scholar
• Sirbu IO, Gresh L, Barra J, Duester G. Shifting boundaries of retinoic acid activity control hindbrain segmental gene expression. Development132, 2611–2622 (2005).
   Google Scholar
• Vaulont S, Kahn A. Transcriptional control of metabolic regulation genes by carbohydrates. FASEB J.8, 28–35 (1994).
   PubMedGoogle Scholar
• Tronche F, Ringeisen F, Blumenfeld M, Yaniv M, Pontoglio M. Analysis of the distribution of binding sites for a tissue-specific transcription factor in the vertebrate genome. J. Mol. Biol.266, 231–245 (1997).
   PubMedGoogle Scholar
• Baumhueter S, Courtois G, Morgan JG, Crabtree GR. The role of HNF-1 in liver-specific gene expression. Ann. NY Acad. Sci.557, 272–279 (1989).
   Google Scholar
• Pontoglio M, Pausa M, Doyen A, Viollet B, Yaniv M, Tedesco F. Hepatocyte nuclear factor 1α controls the expression of terminal complement genes. J. Exp. Med.194, 1683–1689 (2001).
   Google Scholar
• Sakaguchi T, Gu X, Golden HM, Suh E, Rhoads DB, Reinecker HC. Cloning of the human claudin-2 5´-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1α. J. Biol. Chem.277, 21361–21370 (2002).
   PubMed Web of Science ®Google Scholar
• Koffler LD, Fernstrom MJ, Akiyama TE, Gonzalez FJ, Ruch RJ. Positive regulation of connexin32 transcription by hepatocyte nuclear factor-1α. Arch. Biochem. Biophys.407, 160–167 (2002).
   PubMed Web of Science ®Google Scholar
• Torres-Padilla ME, Fougere-Deschatrette C, Weiss MC. Expression of HNF4α isoforms in mouse liver development is regulated by sequential promoter usage and constitutive 3´ end splicing. Mech. Dev.109, 183–193 (2001).
   PubMed Web of Science ®Google Scholar
• Hatzis P, Talianidis I. Regulatory mechanisms controlling human hepatocyte nuclear factor 4α gene expression. Mol. Cell. Biol.21, 7320–7330 (2001).
   PubMed Web of Science ®Google Scholar
• Zhong W, Sladek FM, Darnell JE Jr. The expression pattern of a Drosophila homolog to the mouse transcription factor HNF-4 suggests a determinative role in gut formation. EMBO J.12, 537–544 (1993).
   PubMedGoogle Scholar
• Poll AV, Pierreux CE, Lokmane L et al. A vHNF1/TCF2-HNF6 cascade regulates the transcription factor network that controls generation of pancreatic precursor cells. Diabetes55, 61–69 (2006).
   PubMed Web of Science ®Google Scholar
• Hay CW, Docherty K. Comparative analysis of insulin gene promoters: implications for diabetes research. Diabetes55, 3201–3213 (2006).
   PubMed Web of Science ®Google Scholar
• Pontoglio M. Hepatocyte nuclear factor 1, a transcription factor at the crossroads of glucose homeostasis. J. Am. Soc. Nephrol.11(Suppl. 16), S140–S143 (2000).
   Google Scholar
• Wang H, K Hagenfeldt-Johansson Otten LA, Gauthier BR, Herrera PL, Wollheim CB. Experimental models of transcription factor-associated maturity-onset diabetes of the young. Diabetes51(Suppl. 3), S333–S342 (2002).
   Google Scholar
• Giuffrida FM, Reis AF. Genetic and clinical characteristics of maturity-onset diabetes of the young. Diabetes Obes. Metab.7, 318–326 (2005).
   PubMed Web of Science ®Google Scholar
• Timsit J, C Bellanne-Chantelot D Dubois-Laforgue Velho G. Diagnosis and management of maturity-onset diabetes of the young. Treat. Endocrinol.4, 9–18 (2005).
   PubMedGoogle Scholar
• Olek K. Maturity-onset diabetes of the young: an update. Clin. Lab.52, 593–598 (2006).
   Google Scholar
• Ellard S, Colclough K. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1α (HNF1A) and 4α (HNF4A) in maturity-onset diabetes of the young. Hum. Mutat.27, 854–869 (2006).
   PubMed Web of Science ®Google Scholar
• Lindner TH, Njolstad PR, Horikawa Y, Bostad L, Bell GI, Sovik O. A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1β. Hum. Mol. Genet.8, 2001–2008 (1999).
   PubMed Web of Science ®Google Scholar
• Cereghini S, Ott MO, Power S, Maury M. Expression patterns of vHNF1 and HNF1 homeoproteins in early postimplantation embryos suggest distinct and sequential developmental roles. Development116, 783–797 (1992).
   PubMed Web of Science ®Google Scholar
• Ueda H, Ikegami H, Kawaguchi Y et al. Genetic analysis of late-onset Type 2 diabetes in a mouse model of human complex trait. Diabetes48, 1168–1174 (1999).
   PubMed Web of Science ®Google Scholar
• Herr W, Cleary MA. The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. Genes Dev.9, 1679–1693 (1995).
   PubMed Web of Science ®Google Scholar
• Sourdive DJ, Chouard T, Yaniv M. The HNF1 C-terminal domain contributes to transcriptional activity and modulates nuclear localisation. C. R. Acad. Sci. III.316, 385–394 (1993).
   PubMedGoogle Scholar
• Chouard T, Blumenfeld M, Bach I, Vandekerckhove J, Cereghini S, Yaniv M. A distal dimerization domain is essential for DNA-binding by the atypical HNF1 homeodomain. Nucleic Acids Res.18, 5853–5863 (1990).
   PubMed Web of Science ®Google Scholar
• Rose RB, Bayle JH, Endrizzi JA, Cronk JD, Crabtree GR, Alber T. Structural basis of dimerization, coactivator recognition and MODY3 mutations in Hnf-1α. Nat. Struct. Biol.7, 744–748 (2000).
   Google Scholar
• Narayana N, Hua Q, Weiss MA. The dimerization domain of Hnf-1α: structure and plasticity of an intertwined four-helix bundle with application to diabetes mellitus. J. Mol. Biol.310, 635–658 (2001).
   Google Scholar
• Mendel DB, Khavari PA, Conley PB et al. Characterization of a cofactor that regulates dimerization of a mammalian homeodomain protein. Science254, 1762–1767 (1991).
   PubMed Web of Science ®Google Scholar
• Citron BA, Davis MD, Milstien S et al. Identity of 4a-carbinolamine dehydratase, a component of the phenylalanine hydroxylation system, and DCoH, a transregulator of homeodomain proteins. Proc. Natl Acad. Sci. USA89, 11891–11894 (1992).
   PubMed Web of Science ®Google Scholar
• Pomerantz JL, Sharp PA. Homeodomain determinants of major groove recognition. Biochemistry33, 10851–10858 (1994).
   Google Scholar
• Ceska TA, Lamers M, Monaci P, Nicosia A, Cortese R, Suck D. The x-ray structure of an atypical homeodomain present in the rat liver transcription factor LFB1/HNF1 and implications for binding DNA. EMBO J.12, 1805–1810 (1993).
   Google Scholar
• Tomei L, Cortese R, De Francesco R. A POU-A related region dictates DNA binding specificity of LFB1/HNF1 by orienting the two XL-homeodomains in the dimer. EMBO J.11, 4119–4129 (1992).
   Google Scholar
• Chi YI, Frantz JD, Oh BC, Hansen L, Dhe-Paganon S, Shoelson SE. Diabetes mutations delineate an atypical POU domain in Hnf-1α. Mol. Cell10, 1129–1137 (2002).
   Google Scholar
• Lu P, Rha GB, Chi YI. Structural basis of disease-causing mutations in hepatocyte nuclear factor 1β. Biochemistry46, 12071–12080 (2007).
   Google Scholar
• Deleage G, Combet C, Blanchet C, Geourjon C. ANTHEPROT: an integrated protein sequence analysis software with client/server capabilities. Comput. Biol. Med.31, 259–267 (2001).
   PubMed Web of Science ®Google Scholar
• Sigler PB. Transcriptional activation. Acid blobs and negative noodles. Nature333, 210–212 (1988).
   PubMed Web of Science ®Google Scholar
• Bjorkhaug L, Bratland A, Njolstad PR, Molven A. Functional dissection of the Hnf-1α transcription factor: a study on nuclear localization and transcriptional activation. DNA Cell Biol.24, 661–669 (2005).
   Google Scholar
• Sock E, Enderich J, Rosenfeld MG, Wegner M. Identification of the nuclear localization signal of the POU domain protein Tst-1/Oct6. J. Biol. Chem.271, 17512–17518 (1996).
   PubMedGoogle Scholar
• Holloway JM, Szeto DP, Scully KM, Glass CK, Rosenfeld MG. Pit-1 binding to specific DNA sites as a monomer or dimer determines gene-specific use of a tyrosine-dependent synergy domain. Genes Dev.9, 1992–2006 (1995).
   PubMed Web of Science ®Google Scholar
• Mullis PE. Genetics of growth hormone deficiency. Endocrinol. Metab. Clin. North Am.36, 17–36 (2007).
   Google Scholar
• Soutoglou E, Viollet B, Vaxillaire M, Yaniv M, Pontoglio M, Talianidis I. Transcription factor-dependent regulation of CBP and P/CAF histone acetyltransferase activity. EMBO J.20, 1984–1992 (2001).
   PubMed Web of Science ®Google Scholar
• Carriere V, Lacasa M, Rousset M. Activity of hepatocyte nuclear factor 1α and hepatocyte nuclear factor 1β isoforms is differently affected by the inhibition of protein phosphatases 1/2A. Biochem. J.354, 301–308. (2001).
   Google Scholar
• Bach I, Yaniv M. More potent transcriptional activators or a transdominant inhibitor of the HNF1 homeoprotein family are generated by alternative RNA processing. EMBO J.12, 4229–4242 (1993).
   Google Scholar
• Harries LW, Ellard S, Stride A, Morgan NG, Hattersley AT. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1α show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. Hum. Mol. Genet.15, 2216–2224 (2006).
   PubMed Web of Science ®Google Scholar
• Smale ST. Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes. Biochim. Biophys. Acta1351, 73–88 (1997).
   PubMedGoogle Scholar
• Miura N, Tanaka K. Analysis of the rat hepatocyte nuclear factor (HNF) 1 gene promoter: synergistic activation by HNF4 and HNF1 proteins. Nucleic Acids Res.21, 3731–3736 (1993).
   PubMedGoogle Scholar
• Jung D, GA Kullak-Ublick. Hepatocyte nuclear factor 1α: a key mediator of the effect of bile acids on gene expression. Hepatology37, 622–631 (2003).
   PubMed Web of Science ®Google Scholar
• Godart F, Bellanne-Chantelot C, Clauin S et al. Identification of seven novel nucleotide variants in the hepatocyte nuclear factor-1α (TCF1) promoter region in MODY patients. Hum. Mutat.15, 173–180 (2000).
   Google Scholar
• Lockwood CR, Bingham C, Frayling TM. In silico searching of human and mouse genome data identifies known and unknown HNF1 binding sites upstream of β-cell genes. Mol. Genet. Metab.78, 145–151 (2003).
   Google Scholar
• Power SC, Cereghini S. Positive regulation of the vHNF1 promoter by the orphan receptors COUP-TF1/Ear3 and COUP-TFII/Arp1. Mol. Cell Biol.16, 778–791 (1996).
   PubMedGoogle Scholar
• Gragnoli C, Lindner T, Cockburn BN et al. Maturity-onset diabetes of the young due to a mutation in the hepatocyte nuclear factor-4α binding site in the promoter of the hepatocyte nuclear factor-1α gene. Diabetes46, 1648–1651 (1997).
   Google Scholar
• Yoshiuchi I, Yamagata K, Yoshimoto M et al. Analysis of a non-functional Hnf-1α (TCF1) mutation in Japanese subjects with familial Type 1 diabetes. Hum. Mutat.18, 345–351 (2001).
   Google Scholar
• Thomas H, Badenberg B, Bulman M et al. Evidence for haploinsufficiency of the human HNF1α gene revealed by functional characterization of MODY3-associated mutations. Biol. Chem.383, 1691–1700 (2002).
   Google Scholar
• Stern E, Strihan C, Potievsky O et al. Four novel mutations, including the first gross deletion in TCF1, identified in HNF-4α, GCK and TCF1 in patients with MODY in Israel. J. Pediatr. Endocrinol. Metab.20, 909–921 (2007).
   Google Scholar
• Ellard S, Thomas K, Edghill EL et al. Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young. Diabetologia50, 2313–2317 (2007).
   PubMed Web of Science ®Google Scholar
• Bellanne-Chantelot C, Clauin S, Chauveau D et al. Large genomic rearrangements in the hepatocyte nuclear factor-1β (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young Type 5. Diabetes54, 3126–3132 (2005).
   PubMed Web of Science ®Google Scholar
• Edghill EL, Oram RA, Owens M et al. Hepatocyte nuclear factor-1β gene deletions a common cause of renal disease. Nephrol. Dial. Transplant23(2), 627–635 (2007).
   Google Scholar
• Harries LW, Hattersley AT, Ellard S. Messenger RNA transcripts of the hepatocyte nuclear factor-1α gene containing premature termination codons are subject to nonsense-mediated decay. Diabetes53, 500–504 (2004).
   Google Scholar
• Iwasaki N, Oda N, Ogata M et al. Mutations in the hepatocyte nuclear factor-1α/MODY3 gene in Japanese subjects with early- and late-onset NIDDM. Diabetes46, 1504–1508 (1997).
   Google Scholar
• Bjorkhaug L, Sagen JV, Thorsby P, Sovik O, Molven A, Njolstad PR. Hepatocyte nuclear factor-1α gene mutations and diabetes in Norway. J. Clin. Endocrinol. Metab.88, 920–931 (2003).
   PubMed Web of Science ®Google Scholar
• Stride A, Ellard S, Clark P et al. β-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1α mutation carriers. Diabetes Care28, 1751–1756 (2005).
   Web of Science ®Google Scholar
• Vesterhus M, Raeder H, Johansson S, Molven A, Njolstad PR. Pancreatic exocrine dysfunction in MODY3. Diabetes Care31(2), 306–310 (2007).
   Google Scholar
• Vaxillaire M, Rouard M, Yamagata K et al. Identification of nine novel mutations in the hepatocyte nuclear factor 1α gene associated with maturity-onset diabetes of the young (MODY3). Hum. Mol. Genet.6, 583–586 (1997).
   PubMedGoogle Scholar
• Bingham C, Ellard S, Nicholls AJ et al. The generalized aminoaciduria seen in patients with hepatocyte nuclear factor-1α mutations is a feature of all patients with diabetes and is associated with glucosuria. Diabetes50, 2047–2052 (2001).
   Google Scholar
• Pearson ER, Liddell WG, Shepherd M, Corrall RJ, Hattersley AT. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1α gene mutations. Evidence for pharmacogenetics in diabetes. Diabet. Med.17, 543–545 (2000).
   PubMed Web of Science ®Google Scholar
• Tack CJ, Ellard S, Hattersley AT. A severe clinical phenotype results from the co-inheritance of type 2 susceptibility genes and a hepatocyte nuclear factor-1α mutation. Diabetes Care23, 424–425 (2000).
   Google Scholar
• Malecki MT, Skupien J, Gorczynska-Kosiorz S et al. Renal malformations may be linked to mutations in the hepatocyte nuclear factor-1α (MODY3) gene. Diabetes Care28, 2774–2776 (2005).
   Google Scholar
• Nishigori H, Yamada S, Kohama T et al. Frameshift mutation A263fsinsGG, in the hepatocyte nuclear factor-1β gene associated with diabetes and renal dysfunction. Diabetes47, 1354–1355 (1998).
   PubMedGoogle Scholar
• Kolatsi-Joannou M, Bingham C, Ellard S et al. Hepatocyte nuclear factor-1β: a new kindred with renal cysts and diabetes and gene expression in normal human development. J. Am. Soc. Nephrol.12, 2175–2180 (2001).
   PubMed Web of Science ®Google Scholar
• Bingham C, Bulman MP, Ellard S et al. Mutations in the hepatocyte nuclear factor-1β gene are associated with familial hypoplastic glomerulocystic kidney disease. Am. J. Hum. Genet.68, 219–224 (2001).
   PubMed Web of Science ®Google Scholar
• Bellanne-Chantelot C, Chauveau D, Gautier JF et al. Clinical spectrum associated with hepatocyte nuclear factor-1β mutations. Ann. Intern. Med.140, 510–517 (2004).
   PubMed Web of Science ®Google Scholar
• Edghill EL, Bingham C, Ellard S, Hattersley AT. Mutations in hepatocyte nuclear factor-1β and their related phenotypes. J. Med. Genet.43, 84–90 (2006).
   PubMed Web of Science ®Google Scholar
• Carette C, Vaury C, Barthelemy A et al. Exonic duplication of the hepatocyte nuclear factor-1β gene (transcription factor 2, hepatic) as a cause of maturity onset diabetes of the young type 5. J. Clin. Endocrinol. Metab.92, 2844–2847 (2007).
   PubMed Web of Science ®Google Scholar
• Edghill EL, Bingham C, Slingerland AS et al. Hepatocyte nuclear factor-1β mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1β in human pancreatic development. Diabet. Med.23, 1301–1306 (2006).
   PubMed Web of Science ®Google Scholar
• Haumaitre C, Fabre M, Cormier S, Baumann C, Delezoide AL, Cereghini S. Severe pancreas hypoplasia and multicystic renal dysplasia in two human fetuses carrying novel HNF1β/MODY5 mutations. Hum. Mol. Genet.15, 2363–2375 (2006).
   PubMed Web of Science ®Google Scholar
• Kitanaka S, Miki Y, Hayashi Y, Igarashi T. Promoter-specific repression of hepatocyte nuclear factor (HNF)-1β and Hnf-1α transcriptional activity by an HNF-1β missense mutant associated with Type 5 maturity-onset diabetes of the young with hepatic and biliary manifestations. J. Clin. Endocrinol. Metab.89, 1369–1378 (2004).
   PubMed Web of Science ®Google Scholar
• Yoshiuchi I, Yamagata K, Zhu Q et al. Identification of a gain-of-function mutation in the HNF-1β gene in a Japanese family with MODY. Diabetologia45, 154–155 (2002).
   PubMed Web of Science ®Google Scholar
• Sovik O, Sagen J, Njolstad PR, Nyland H, Myhr KM. Contributions to the MODY5 phenotype. J. Inherit. Metab. Dis.25, 597–598 (2002).
   Google Scholar
• Pearson ER, Badman MK, Lockwood CR et al. Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1α and -1β mutations. Diabetes Care27, 1102–1107 (2004).
   PubMed Web of Science ®Google Scholar
• Ek J, Grarup N, Urhammer SA et al. Studies of the variability of the hepatocyte nuclear factor-1β (HNF-1β/TCF2) and the dimerization cofactor of HNF-1 (DCoH/PCBD) genes in relation to Type 2 diabetes mellitus and β-cell function. Hum. Mutat.18, 356–357 (2001).
   Google Scholar
• Manduchi E, Grant GR, He H et al. RAD and the RAD Study-Annotator: an approach to collection, organization and exchange of all relevant information for high-throughput gene expression studies. Bioinformatics20, 452–459 (2004).
   PubMed Web of Science ®Google Scholar
• Bayle JH, Randazzo F, Johnen G et al. Hyperphenylalaninemia and impaired glucose tolerance in mice lacking the bifunctional DCoH gene. J. Biol. Chem.277, 28884–28891 (2002).
   Google Scholar
• Rose RB, Pullen KE, Bayle JH, Crabtree GR, Alber T. Biochemical and structural basis for partially redundant enzymatic and transcriptional functions of DCoH and DCoH2. Biochemistry43, 7345–7355 (2004).
   Google Scholar
• Ott MO, Rey-Campos J, Cereghini S, Yaniv M. vHNF1 is expressed in epithelial cells of distinct embryonic origin during development and precedes HNF1 expression. Mech. Dev.36, 47–58 (1991).
   PubMed Web of Science ®Google Scholar
• Coffinier C, Barra J, Babinet C, Yaniv M. Expression of the vHNF1/HNF1β homeoprotein gene during mouse organogenesis. Mech. Dev.89, 211–213 (1999).
   PubMed Web of Science ®Google Scholar
• Nammo T, Yamagata K, Hamaoka R et al. Expression profile of MODY3/Hnf-1α protein in the developing mouse pancreas. Diabetologia45, 1142–1153 (2002).
   PubMed Web of Science ®Google Scholar
• Offield MF, Jetton TL, Labosky PA et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development122, 983–995 (1996).
   PubMed Web of Science ®Google Scholar
• Ahlgren U, Jonsson J, Jonsson L, Simu K, Edlund H. β-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the β-cell phenotype and maturity onset diabetes. Genes Dev.12, 1763–1768 (1998).
   PubMed Web of Science ®Google Scholar
• Schwitzgebel VM, Scheel DW, Conners JR et al. Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. Development127, 3533–3542 (2000).
   PubMed Web of Science ®Google Scholar
• Gradwohl G, Dierich A, LeMeur M, Guillemot F. Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc. Natl Acad. Sci. USA97, 1607–1611 (2000).
   PubMed Web of Science ®Google Scholar
• Gu G, Dubauskaite J, Melton DA. Direct evidence for the pancreatic lineage. NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development129, 2447–2457 (2002).
   PubMed Web of Science ®Google Scholar
• Haumaitre C, Reber M, Cereghini S. Functions of HNF1 family members in differentiation of the visceral endoderm cell lineage. J. Biol. Chem.278, 40933–40942 (2003).
   PubMedGoogle Scholar
• Wang L, Coffinier C, Thomas MK et al. Selective deletion of the Hnf1β (MODY5) gene in β cells leads to altered gene expression and defective insulin release. Endocrinology145, 3941–3949 (2004).
   PubMed Web of Science ®Google Scholar
• Welters HJ, Senkel S, Klein-Hitpass L et al. Conditional expression of hepatocyte nuclear factor-1β, the maturity-onset diabetes of the young-5 gene product, influences the viability and functional competence of pancreatic β-cells. J. Endocrinol.190, 171–181 (2006).
   PubMed Web of Science ®Google Scholar
• Pontoglio M, Sreenan S, Roe M et al. Defective insulin secretion in hepatocyte nuclear factor 1α-deficient mice. J. Clin. Invest.101, 2215–2222 (1998).
   PubMed Web of Science ®Google Scholar
• Dukes ID, Sreenan S, Roe MW et al. Defective pancreatic β-cell glycolytic signaling in hepatocyte nuclear factor-1α-deficient mice. J. Biol. Chem.273, 24457–24464 (1998).
   PubMed Web of Science ®Google Scholar
• Yamagata K, Nammo T, Moriwaki M et al. Overexpression of dominant-negative mutant hepatocyte nuclear factor-1α in pancreatic β-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced β-cell proliferation, and diabetes. Diabetes51, 114–123 (2002).
   PubMed Web of Science ®Google Scholar
• Ferrer J. A genetic switch in pancreatic β-cells: implications for differentiation and haploinsufficiency. Diabetes51, 2355–2362 (2002).
   PubMed Web of Science ®Google Scholar
• Servitja JM, Ferrer J. Transcriptional networks controlling pancreatic development and β cell function. Diabetologia47, 597–613 (2004).
   PubMedGoogle Scholar
• Furuta H, Iwasaki N, Oda N et al. Organization and partial sequence of the hepatocyte nuclear factor-4α/MODY1 gene and identification of a missense mutation R127W, in a Japanese family with MODY. Diabetes46, 1652–1657 (1997).
   PubMedGoogle Scholar
• Nakhei H, Lingott A, Lemm I, Ryffel GU. An alternative splice variant of the tissue specific transcription factor HNF4α predominates in undifferentiated murine cell types. Nucleic Acids Res.26, 497–504 (1998).
   PubMedGoogle Scholar
• Kritis AA, Ktistaki E, Barda D, Zannis VI, Talianidis I. An indirect negative autoregulatory mechanism involved in hepatocyte nuclear factor-1 gene expression. Nucleic Acids Res.21, 5882–5889 (1993).
   PubMedGoogle Scholar
• Boj SF, Parrizas M, Maestro MA, Ferrer J. A transcription factor regulatory circuit in differentiated pancreatic cells. Proc. Natl Acad. Sci. USA98, 14481–14486 (2001).
   PubMed Web of Science ®Google Scholar
• Bingham C, Ellard S, Allen L et al. Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1β. Kidney Int.57, 898–907 (2000).
   PubMed Web of Science ®Google Scholar
• Iwasaki N, Okabe I, Momoi MY, Ohashi H, Ogata M, Iwamoto Y. Splice site mutation in the hepatocyte nuclear factor-1β gene IVS2nt + 1G > A, associated with maturity-onset diabetes of the young, renal dysplasia and bicornuate uterus. Diabetologia44, 387–388 (2001).
   PubMed Web of Science ®Google Scholar
• Carbone I, Cotellessa M, Barella C et al. A novel hepatocyte nuclear factor-1β (MODY-5) gene mutation in an Italian family with renal dysfunctions and early-onset diabetes. Diabetologia45, 153–154 (2002).
   Google Scholar
• Bingham C, Ellard S, Cole TR et al. Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1β mutations. Kidney Int.61, 1243–1251 (2002).
   PubMed Web of Science ®Google Scholar